Open: | 0.093081 |
Change: | +0.000312 |
Volume: | 0 |
Low: | 0.091063 |
High: | 0.093345 |
High / Low range: | 0.002282 |
Type: | Stocks |
Ticker: | SAN |
ISIN: | FR0000120578 |
SANOFI - 1H - Technical analysis published on 04/19/2023 (GMT)
- 218
- 0
- 04/19/2023 - 11:03
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on 04/19/2023 - 11:03
- Status : LEVEL MAINTAINED
Analysis too old. There are no more charts available.
Summary of the analysis
Additional analysis
Quotes
The SANOFI rating is 101.36 EUR. On the day, this instrument lost -0.02% with the lowest point at 100.92 EUR and the highest point at 101.52 EUR. The deviation from the price is +0.44% for the low point and -0.16% for the high point.The Central Gaps scanner detects a bearish opening marking the presence of sellers ahead of buyers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by SANOFI:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in 1H of this SANOFI chart shows a slightly bearish trend. Only 53.57% of the signals given by moving averages are bearish. This slightly bearish trend is reinforced by the strong signals currently being given by short-term moving averages. The Central Indicators scanner detects a bearish signal on moving averages that could impact this trend:
Moving Average bearish crossovers : MA20 & MA50
Type : Bearish
Timeframe : 1 hour
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : 1 hour
RSI indicator: bullish divergence
Type : Bullish
Timeframe : 1 hour
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : 1 hour
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows several results that can have an impact on the price change:
Near horizontal support
Type : Bullish
Timeframe : 1 hour
Support of channel is broken
Type : Bearish
Timeframe : 1 hour
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | |
---|---|---|---|---|---|
ProTrendLines | 90.89 | 98.97 | 101.00 | 101.36 | 103.72 |
Change (%) | -10.33% | -2.36% | -0.36% | - | +2.33% |
Change | -10.47 | -2.39 | -0.36 | - | +2.36 |
Level | Minor | Major | Intermediate | - | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 98.93 | 100.01 | 100.69 | 101.77 | 102.45 | 103.53 | 104.21 |
Camarilla | 100.90 | 101.06 | 101.22 | 101.38 | 101.54 | 101.70 | 101.86 |
Woodie | 98.74 | 99.91 | 100.50 | 101.67 | 102.26 | 103.43 | 104.02 |
Fibonacci | 100.01 | 100.68 | 101.09 | 101.77 | 102.44 | 102.85 | 103.53 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 97.34 | 98.68 | 100.36 | 101.70 | 103.38 | 104.72 | 106.40 |
Camarilla | 101.21 | 101.49 | 101.76 | 102.04 | 102.32 | 102.59 | 102.87 |
Woodie | 97.51 | 98.77 | 100.53 | 101.79 | 103.55 | 104.81 | 106.57 |
Fibonacci | 98.68 | 99.83 | 100.55 | 101.70 | 102.85 | 103.57 | 104.72 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 77.67 | 82.55 | 91.39 | 96.27 | 105.11 | 109.99 | 118.83 |
Camarilla | 96.47 | 97.73 | 98.98 | 100.24 | 101.50 | 102.76 | 104.01 |
Woodie | 79.66 | 83.54 | 93.38 | 97.26 | 107.10 | 110.98 | 120.82 |
Fibonacci | 82.55 | 87.79 | 91.03 | 96.27 | 101.51 | 104.75 | 109.99 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 35.66 | |
MACD (12,26,9): | -0.2400 | |
Directional Movement: | -9.78 | |
AROON (14): | -21.43 | |
DEMA (21): | 101.56 | |
Parabolic SAR (0,02-0,02-0,2): | 102.46 | |
Elder Ray (13): | -0.46 | |
Super Trend (3,10): | 102.46 | |
Zig ZAG (10): | 101.20 | |
VORTEX (21): | 0.9500 | |
Stochastique (14,3,5): | 18.75 | |
TEMA (21): | 101.29 | |
Williams %R (14): | -85.42 | |
Chande Momentum Oscillator (20): | -1.24 | |
Repulse (5,40,3): | -0.1400 | |
ROCnROLL: | 2 | |
TRIX (15,9): | -0.0200 | |
Courbe Coppock: | 1.88 |
MA7: | 101.75 | |
MA20: | 99.42 | |
MA50: | 93.26 | |
MA100: | 91.35 | |
MAexp7: | 101.45 | |
MAexp20: | 101.80 | |
MAexp50: | 101.84 | |
MAexp100: | 101.01 | |
Price / MA7: | -0.38% | |
Price / MA20: | +1.95% | |
Price / MA50: | +8.69% | |
Price / MA100: | +10.96% | |
Price / MAexp7: | -0.09% | |
Price / MAexp20: | -0.43% | |
Price / MAexp50: | -0.47% | |
Price / MAexp100: | +0.35% |
News
Don't forget to follow the news on SANOFI. At the time of publication of this analysis, the latest news was as follows:
- 04/11/2023 - 06:00 Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
- 04/10/2023 - 20:15 Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.
- 03/23/2023 - 06:00 Press Release: Dupixent® demonstrates potential to become first biologic to treat COPD by showing significant reduction in exacerbations in pivotal trial
- 03/16/2023 - 20:06 Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance
- 03/07/2023 - 06:00 Press Release: Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review
Add a comment
Comments
0 comments on the analysis SANOFI - 1H